Silverarc Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-127,835
| Closed | -$5.98M | – | 71 |
|
|
2024
Q1 | $5.98M | Buy |
+127,835
| New | +$5.98M | 1.66% | 23 |
|
|
2023
Q4 | – | Sell |
-220,000
| Closed | -$6.54M | – | 70 |
|
|
2023
Q3 | $6.54M | Buy |
+220,000
| New | +$6.54M | 1.98% | 15 |
|
|
2023
Q1 | – | Sell |
-152,747
| Closed | -$2.8M | – | 77 |
|
|
2022
Q4 | $2.8M | Buy |
152,747
+3,720
| +2% | +$68.1K | 0.8% | 39 |
|
|
2022
Q3 | $2.93M | Buy |
149,027
+9,488
| +7% | +$186K | 0.99% | 26 |
|
|
2022
Q2 | $2.6M | Buy |
139,539
+25,535
| +22% | +$476K | 0.8% | 25 |
|
|
2022
Q1 | $2.5K | Buy |
114,004
+2,144
| +2% | +$47 | 1.04% | 24 |
|
|
2021
Q4 | $3.18M | Buy |
111,860
+62,478
| +127% | +$1.78M | 1.29% | 24 |
|
|
2021
Q3 | $1.04M | Buy |
+49,382
| New | +$1.04M | 0.59% | 54 |
|